Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-07

Clinical Trial Update: Healing Effects of Autologous Platelet Rich Plasma on Gastric Ulcer Caused by Endoscopic Submucosal Dissection [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating the healing effects of autologous platelet-rich plasma on gastric ulcers caused by endoscopic submucosal dissection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous Platelet-Rich Plasma (platelet-rich plasma)

Snippet

Sponsor: Keimyung University Dongsan Medical Center | Conditions: Platelet-rich Plasma, Endoscopic Submucosal Dissection | Phase 3 | Status: COMPLETED